The effect of community-acquired pneumonia on plasma esterases in older people

被引:10
作者
Abou-Hatab, K
Ganeshalingam, K
O'Mahony, MS [1 ]
Giurani, F
Patel, S
Woodhouse, K
机构
[1] Llandough Hosp, Acad Ctr, Dept Geriatr Med, Penarth CF64 2XX, S Glam, Wales
[2] Llandough Hosp, Dept Resp Med, Penarth CF64 2XX, S Glam, Wales
关键词
esterases; cytochrome P-450; pneumonia;
D O I
10.1007/s002280000259
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Pneumonia is a major cause of morbidity and mortality in older people. The poor outcome of older pneumonia patients despite treatment is still not understood. Objective: The aim of this study was to examine the effect of community-acquired pneumonia on enzymes of drug metabolism in older people. Methods: Fifteen patients (median age 67 years) with a clinical and radiological diagnosis of community-acquired pneumonia and 14 healthy volunteers matched for ae and gender (median age 75 years) were recruited, Plasma activities of benzoylcholinesterase, butyrylcholinesterase. acetylcholinesterase and aspirin esterase were determined spectrophotometrically; at three time points in pneumonia patients - within 24 h of admission to hospital, 2 days later and 10 days later. Monocyte aryl hydrocarbon hydroxylase (AHH) activity was determined spectrofluorimetrically at the same time points. Enzyme activities were measured at one time Feint in healthy controls. Results: Mean plasma benzoylcholinesterase activity was significantly lower in pneumonia patients on admission to hospital (mean +/- SEM 848 +/- 100) and after 10 days of treatment (mean +/- SEM 925 +/- 114) than in healthy controls (mean +/- SEM 1333 +/- 84, P < 0.05). Similarly: plasma acetylcholinesterase activity was significantly lower in pneumonia patients on admission (P = 0.007) and after 10 days of treatment (P = 0.01) than in controls. Butyrylcholinesterase activity was lower in pneumonia patients on admission (P = 0.029) than in healthy controls, but improved slightly after treatment so there was no longer a significant difference at 10 days compared with controls (P = 0.077). In contrast there were no significant differences in plasma aspirin esterase activity or induced monocyte AHH activity between pneumonia patients and healthy controls. The activities of benzoylcholinesterase (r = -0.536, P = 0.04), butyrylcholinesterase (r = -0.638, P = 0.04), acetylcholinesterase (r = -0.583, P = 0.022) and aspirin esterase (r = -0.624, P = 0.013) correlated inversely with the British Thoracic Society pneumonia poor prognostic index. Conclusion: The activities of several esterases are reduced in older pneumonia patients. Other enzymes including aspirin esterase and induced monocyte AHH activity are unaltered in pneumonia. There was a significant inverse relationship between the activities of all esterases studied and the British Thoracic Society pneumonia poor prognostic index.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 31 条
  • [1] ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
  • [2] Plasma esterases in cystic fibrosis: the impact of a respiratory exacerbation and its treatment
    Abou-Hatab, K
    Nixon, LS
    O'Mahony, MS
    Newsway, V
    Patel, S
    Shale, DJ
    Woodhouse, KW
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 54 (12) : 937 - 941
  • [3] ANARI MR, 1993, BIOCHEM PHARMACOL, V46, P307
  • [4] ANDREWS BE, 1987, Q J MED, V62, P195
  • [5] Blouin RA, 1999, J BIOCHEM MOL TOXIC, V13, P215, DOI 10.1002/(SICI)1099-0461(1999)13:3/4<215::AID-JBT12>3.0.CO
  • [6] 2-5
  • [7] LEVELS OF AZITHROMYCIN AND ALPHA-1-ACID GLYCOPROTEIN IN SERUM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
    BOHTE, R
    MATTIE, H
    VANDERBROEK, PJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) : 2801 - 2802
  • [8] MECHANISMS OF INTERLEUKIN-2-INDUCED DEPRESSION OF HEPATIC CYTOCHROME-P-450 IN MICE
    CANTONI, L
    CARELLI, M
    GHEZZI, P
    DELGADO, R
    FAGGIONI, R
    RIZZARDINI, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 292 (3-4): : 257 - 263
  • [9] ACUTE-PHASE RESPONSE, INTERLEUKIN-6, AND ALTERATION OF CYCLOSPORINE PHARMACOKINETICS
    CHEN, YL
    LEVRAUX, V
    LENEVEU, A
    DREYFUS, F
    STHENEUR, A
    FLORENTIN, I
    DESOUSA, M
    GIROUD, JP
    FLOUVAT, B
    CHAUVELOTMOACHON, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) : 649 - 660
  • [10] Cholinesterase - Its significance in anaesthetic practice
    Davis, L
    Britten, JJ
    Morgan, M
    [J]. ANAESTHESIA, 1997, 52 (03) : 244 - 260